Sumitomo Pharma : Start of Phase 1 Clinical Study on Novel Universal Influenza Vaccine Candidate marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Eisai and National Cancer Center Commence Joint Research and Development Project
Using PDX With High Predictability of Clinical Outcomes, and Cancer Genome Data
TOKYO, May 14, 2021 - (JCN Newswire) - Eisai Co., Ltd. and the National Cancer Center Japan announced today that both parties have entered into a joint research and development (R&D) agreement concerning Basic research on the drug discovery and development to accelerate development of anticancer drugs in treatment of patients with rare cancers and refractory cancers , and that research activities have commenced. This R&D project is to be carried out with funding under the program Cyclic Innovation for Clinical Empowerment (CiCLE) established by the Japan Agency for Medical Research and Development (AMED).